Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Novugen Pharma (USA) LLC, priced at $0.0717 per EA under NDC 82293000310. Its NADAC has been published 132 times since Dec 20, 2023.
Strength
2.5 mg/1
Manufacturer
Novugen Pharma (USA) LLCNDC
82293000310
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211973On Market Since
10/18/2023
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 132 times since Dec 20, 2023, and over the history we have for it it has declined 50.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0717 per EA |
|---|---|
| All-time high | $0.1446 (Jan 10, 2024) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0857 |
| 52-week low | $0.0712 |
| Median price | $0.0829 |
| Average price | $0.0879 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 132 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Novugen Pharma (USA) LLC, is $0.0717 per EA (NDC 82293000310), effective Jun 24, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 50.4%. It has been tracked across 132 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Dec 20, 2023, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.1446 (Jan 10, 2024), with a median of $0.0829 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
11 NADAC-published products share the same active ingredient, strength, and dosage form as MIDODRINE HCL 2.5 MG TABLET, but none are currently priced below it.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 82293000310) is labeled by Novugen Pharma (USA) LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification